- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02198755
Detection of Osteomyelitis Using High Resolution Ultrasound
July 23, 2014 updated by: Oscar M. Alvarez, PhD, Calvary Hospital, Bronx, NY
Sensitivity, Specificity and Predictive Value of High Resolution (B-Mode) Ultrasonography (HRUS) for the Detection of Osteomyelitis in Chronic Wound Patients
The purpose of this study is to establish the sensitivity of HRUS as compared to MRI for the diagnosis of osteomyelitis in chronic wound patients; and to determine the specificity of HRUS as compared to pathologic and microbiologic studies of bone biopsy tissues.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Bronx, New York, United States, 10461
- Center for Curative and Palliative wound Care, Calvary Hospital
-
Contact:
- Tashara Smith, BS
- Phone Number: 718-518-2577
- Email: tsmith@calvaryhospital.org
-
Sub-Investigator:
- Martin Wendeken, DPM, RN
-
Principal Investigator:
- Oscar M Alvarez, PhD
-
Sub-Investigator:
- Lee Markowitz, DPM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient may be of any race and between 18-85 years of age.
- Patient has a current diagnosis of a chronic ulcer with suspected osteomyelitis.
- Patient's ulcer may be due to any etiology including but not limited to diabetes, trauma, neuropathic, pressure, venous, arterial, and inflammatory.
- Patient's ulcer may extend through the dermis and into subcutaneous tissue (granulation tissue may be present), and may include exposure of muscle, tendon, bone, or joint capsule.
- Patient's ulcer is suspected of causing a bone infection.
- Patient's ulcer may be of any size.
- Patient's wound may present with non-viable tissue.
- Patient circulation to the wound should be evaluated and treated using normal protocol.
- Patient's diabetes is under control as determined by the Investigator. Patients must have an HbA1c value less than 13.0%. Those patients whose glucose level is not deemed to be in control should be referred to their primary physician for treatment of the hyperglycemia.
- Patient and caregiver are willing to participate in the clinical study and comply with the follow-up regimen.
- Patient or his/her legal representative has read and signed the Institutional Review Board (IRB) approved Informed Consent form before treatment.
- If patient is capable of childbirth, she is using medically accepted means of birth control, and she tests negative on a serum pregnancy test.
- Active localized acute wound infection or cellulitis: Subject may be considered for study enrollment after the signs and symptoms of acute infection have resolved.
Exclusion Criteria:
Subject has a condition where an MRI is contraindicated
- Metallic fragments, clips or devices in the brain, eye, spinal canal, etc.: (Plain radiography is sufficient for screening
- Magnetically activated implanted devices:
Cardiac pacemakers, insulin pumps, neuro¬stim¬u¬lators, cochlear implants, etc. may be de-programmed.
- Non-graphite spinal cord tongs: Graphite tongs are compatible.
- Thermodilution Swan-Ganz catheter: Local heating can result. If unenhanced MRI is likely to provide sufficient information, gadolinium should not be administered to these patients. If, after review of clinical indications, gadolinium enhancement is judged to be important for diagnosis, the lowest effective dose of contrast agent should be used.
In subjects where gadolinium enhancement MRI is planned then the following exclusion criteria apply:
- Subject is allergic to contrast materials or cannot tolerate gadolinium
- Subject is at risk of nephrogenic systemic fibrosis (NSF) or has severe renal failure (as determined by the investigator)
- Patient must not be pregnant.
- Patient has any condition(s) that seriously compromises the patient's ability to complete this study.
- Patient with recent surgical debridement of the bone in and around the ulcer site.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: High Resolution Ultrasound
High Resolution Ultrasonography (HRUS) with a Hitachi-Aloka Noblus Scanner
|
High resolution ultrasound with the Hitachi-Aloka Noblus Scanner and a 8-15mHz transducer
|
Active Comparator: Magnetic Resonance Imaging (MRI)
|
MRI with or without contrast
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percent sensitivity and specificity of HRUS as compared to MRI and bone biopsy
Time Frame: at 3 weeks
|
at 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Oscar M Alvarez, PhD, Director, Wound Care Center, Calvary Hospital
- Study Director: Martin Wendelken, DPM, RN, Staff Podiatrist, Wound Care Center, Calvary Hospital, Bronx, NY
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
June 1, 2016
Study Registration Dates
First Submitted
July 22, 2014
First Submitted That Met QC Criteria
July 23, 2014
First Posted (Estimate)
July 24, 2014
Study Record Updates
Last Update Posted (Estimate)
July 24, 2014
Last Update Submitted That Met QC Criteria
July 23, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 100-Osteo-HRUS-0601
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Osteomyelitis
-
Seattle Children's HospitalMansoura University; Boston Children's Hospital, Boston, MA, USA; Hospital for... and other collaboratorsRecruitingChronic Recurrent Multifocal Osteomyelitis | Chronic Nonbacterial OsteomyelitisUnited States
-
Hospices Civils de LyonRecruiting
-
Seattle Children's HospitalUniversity of WashingtonRecruitingChronic Recurrent Multifocal OsteomyelitisUnited States
-
Hospices Civils de LyonCompletedChronic Recurrent Multifocal OsteomyelitisFrance
-
Rigshospitalet, DenmarkRegion SjællandActive, not recruitingChronic Recurrent Multifocal OsteomyelitisDenmark
-
Rigshospitalet, DenmarkRecruitingOsteomyelitis; VertebraDenmark
-
University of LouisvilleOsteo Science FoundationNot yet recruitingOsteomyelitis of JawUnited States
-
Asan Medical CenterCompletedVertebral OsteomyelitisKorea, Republic of
-
Cubist Pharmaceuticals LLCCompleted
-
Hospices Civils de LyonCompletedOsteomyelitis | Hematogenous Osteomyelitis RelapseFrance
Clinical Trials on Hitachi-Aloka Noblus ultrasound scanner
-
Centre Hospitalier Universitaire de Saint EtienneCompletedGait | Child Development | HemiplegicFrance
-
Stanford UniversityCompletedNeed for Central Venous AccessUnited States
-
QT Ultrasound LLCAnalysis Group, Inc.SuspendedBreast Cancer ScreeningUnited States
-
Washington University School of MedicineCompleted
-
Mayo ClinicUnited States Department of DefenseRecruiting
-
Johannes VermehrenCompleted
-
RWTH Aachen UniversityUnknownAngina Pectoris | Left Ventricular Wall Motion AbnormalitiesGermany
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Cancer Institute (NCI); University of California, San Diego; GE Healthcare and other collaboratorsCompletedHepatocellular Carcinoma | Chemoembolization, TherapeuticUnited States
-
Northwestern UniversitySiemens Medical SolutionsCompletedBreast DiseasesUnited States
-
Olympus Corporation of the AmericasGeisinger ClinicCompleted